These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 7969823)
61. Somatotropic adenomas without acromegaly. Trouillas J; Sassolas G; Loras B; Velkeniers B; Raccurt M; Chotard L; Berthezène F; Tourniaire J; Girod C Pathol Res Pract; 1991 Dec; 187(8):943-9. PubMed ID: 1792190 [TBL] [Abstract][Full Text] [Related]
62. Factors affecting the outcome of surgical treatment of acromegaly. Er LK; Chang TC; Lin SM; Huang KM; Chang CC J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950 [TBL] [Abstract][Full Text] [Related]
63. MIB1 immunopositivity is associated with rapid regrowth of pituitary adenomas. Mizoue T; Kawamoto H; Arita K; Kurisu K; Tominaga A; Uozumi T Acta Neurochir (Wien); 1997; 139(5):426-31; discussion 431-2. PubMed ID: 9204112 [TBL] [Abstract][Full Text] [Related]
64. Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiosurgery. Yoon SC; Suh TS; Jang HS; Chung SM; Kim YS; Ryu MR; Choi KH; Son HY; Kim MC; Shinn KS Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):849-53. PubMed ID: 9652848 [TBL] [Abstract][Full Text] [Related]
66. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082 [TBL] [Abstract][Full Text] [Related]
67. Pituitary surgery in elderly patients with acromegaly. Puchner MJ; Knappe UJ; Lüdecke DK Neurosurgery; 1995 Apr; 36(4):677-83; discussion 683-4. PubMed ID: 7596496 [TBL] [Abstract][Full Text] [Related]
68. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma. Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083 [TBL] [Abstract][Full Text] [Related]
69. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Lampropoulos KI; Samonis G; Nomikos P Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694 [TBL] [Abstract][Full Text] [Related]
70. Diagnosis and treatment of pituitary adenomas. Chanson P; Salenave S Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032 [TBL] [Abstract][Full Text] [Related]
71. Acromegaly with normal basal growth hormone levels. Mohr G; Chen ZP; Schweitzer M Can J Neurol Sci; 1997 Aug; 24(3):250-3. PubMed ID: 9276113 [TBL] [Abstract][Full Text] [Related]
72. Identification of somatotrophs, mammosomatotrophs, and mammotrophs by sandwich cell immunoblot assay in GH-secreting adenomas and prolactinomas: correlations between the proportions of hormone secreting cells and tumor size. Kojima Y; Suzuki S; Yamamura K; Kawasaki T; Yamamoto I Endocr J; 2000 Apr; 47(2):143-55. PubMed ID: 10943738 [TBL] [Abstract][Full Text] [Related]
73. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918 [TBL] [Abstract][Full Text] [Related]
74. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464 [TBL] [Abstract][Full Text] [Related]
75. Growth hormone secretion in recently operated acromegalic patients. van den Berg G; Frölich M; Veldhuis JD; Roelfsema F J Clin Endocrinol Metab; 1994 Dec; 79(6):1706-15. PubMed ID: 7989479 [TBL] [Abstract][Full Text] [Related]
76. Double pituitary adenomas: six surgical cases. Sano T; Horiguchi H; Xu B; Li C; Hino A; Sakaki M; Kannuki S; Yamada S Pituitary; 1999 May; 1(3-4):243-50. PubMed ID: 11081204 [TBL] [Abstract][Full Text] [Related]
77. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy. Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356 [TBL] [Abstract][Full Text] [Related]
78. Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas. Kim HJ; Kim MS; Park YJ; Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Jung HW; Han DH; Lee HS; Chi JG J Endocrinol; 2001 Feb; 168(2):221-6. PubMed ID: 11182759 [TBL] [Abstract][Full Text] [Related]
79. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings. Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915 [TBL] [Abstract][Full Text] [Related]
80. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. Shimon I; Yan X; Taylor JE; Weiss MH; Culler MD; Melmed S J Clin Invest; 1997 Nov; 100(9):2386-92. PubMed ID: 9410919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]